| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/07/2004 | WO2004026252A3 Glioma treatments |
| 10/07/2004 | WO2004021999A3 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 10/07/2004 | WO2004019873A3 Methods of promoting osteogenesis |
| 10/07/2004 | WO2004016242A8 A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles |
| 10/07/2004 | WO2004012659A3 Nitrosated proton pump inhibitors, compositions and methods of use |
| 10/07/2004 | WO2004007709A3 Production of polyketides |
| 10/07/2004 | WO2004002418A3 Compositions and methods comprising protein activated receptor antagonists |
| 10/07/2004 | WO2004002402A3 Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
| 10/07/2004 | WO2003105770A3 Carbocyclic nucleoside analogs as rna-antivirals |
| 10/07/2004 | WO2003101386A3 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 10/07/2004 | WO2003099195A3 Immunomodulatory compounds and methods of use thereof |
| 10/07/2004 | WO2003078430A8 Amides of acetic and propionic acids |
| 10/07/2004 | WO2003076446A8 Antiparasitic artemisinin derivatives (endoperoxides) |
| 10/07/2004 | WO2003076427A8 Quinazoline compounds useful in therapy |
| 10/07/2004 | WO2003074027A8 Self emulsifying drug delivery systems for poorly soluble drugs |
| 10/07/2004 | WO2003072106A8 Use of tyrosine kinase inhibitors for treating substance use disorders |
| 10/07/2004 | WO2003068757A9 Novel pyridin- and pyrimidin-derivatives |
| 10/07/2004 | WO2003068748A9 Novel pyridine- and quinoline-derivatives |
| 10/07/2004 | WO2003053973A8 Pyrazolyl-substituted triazoloquinoxalines |
| 10/07/2004 | WO2003049679A3 Mitotic kinesin inhibitors |
| 10/07/2004 | WO2002100250A8 Wit 3.0, a novel gene to control soft tissue wound healing |
| 10/07/2004 | WO2002083059A3 Use of esters of long-chain fatty acids for treatment of autoimmune diseases |
| 10/07/2004 | US20040199207 Polyester/cyanoacrylate tissue adhesive compositions |
| 10/07/2004 | US20040199130 Apparatus and method for treatment of macular degeneration |
| 10/07/2004 | US20040199028 Non-halogenated hydroxyalkyl-substituted phenol compounds, antimicrobial compositions containing the same, and methods of using the same |
| 10/07/2004 | US20040198987 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use |
| 10/07/2004 | US20040198983 including fexofenadine; novel synthetic intermediate 2-(4-{4-(Hydroxydiphenyl-methyl)-piperidine-1-yl]-4-oxo-butyryl}-phenyl)-2-2-methyl-propionic Acid lower alkyl ester |
| 10/07/2004 | US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis |
| 10/07/2004 | US20040198981 Tricyclic dihydroquinoline derivatives,method for preparing same and pharmaceutical compositions containing same |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198978 for treating autoimmune diseases selected from psoriasis, multiple sclerosis and rheumatoid arthritis; N-(3-oxoundecanoyl)-L-homoserine lactone (OuDHL) and 2-n-heptyl-3-hydroxy-4(1H)-quinolone for example |
| 10/07/2004 | US20040198976 Method for synthesizing pyrazolobenzodiazepines |
| 10/07/2004 | US20040198967 Expression vector comprising RNA interference sequences for use as transcription suppression tool in target gene therapy |
| 10/07/2004 | US20040198841 Pretreatment before chemotherapy; antiulcer agents for cancer therapy |
| 10/07/2004 | US20040198840 Hydrazide substrate safely shuts down disease activated protease to halt viral replication, cancerous cell division, and toxic protein generation |
| 10/07/2004 | US20040198839 Cardioprotective dosage units |
| 10/07/2004 | US20040198838 Administering by mouth; side effect reduction; multilayer coating on tablet; fungicides |
| 10/07/2004 | US20040198837 Using 1-( 1- ( 4-chlorophenyl)cyckobutyl)-3-methylamine hydrochloride, or related compounds |
| 10/07/2004 | US20040198836 reacting 1-(2,5-dimethoxyphenyl)-2-bromoethanone with hexamine, then acylating with haloacetylchloride and sodium acetate, selectively reducing with sodium borohydride and stannous chloride, and quaternization, to form midodrine and salts, used as hypertensive agents |
| 10/07/2004 | US20040198834 Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 10/07/2004 | US20040198832 Compositions and methods for treating amyloidosis |
| 10/07/2004 | US20040198831 Remedial agent for arthrosis deformans |
| 10/07/2004 | US20040198829 Adjust transportation of active material to eye |
| 10/07/2004 | US20040198828 Combinational use of long-acting and short-acting anti-histamines for ocular allergies |
| 10/07/2004 | US20040198827 Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases |
| 10/07/2004 | US20040198826 Pharmaceutical combination for treating benign prostatic hyperplasia or for treating abacterial prostatitis |
| 10/07/2004 | US20040198824 enzyme inhibitor; anticancer agents; analgesics; vision defects |
| 10/07/2004 | US20040198823 Process for preparing a creatine heterocyclic acid salt and method of use. |
| 10/07/2004 | US20040198822 Using gabapentin, pregabalin; synergistic mixture with anticholinergic agents |
| 10/07/2004 | US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 10/07/2004 | US20040198819 Intensifier for anticancer, antitumor agents; mixture of 3-hydroxybutyric acid, lactic acid, acetic acid, creatinine, carnitine, taurine, choline and urea |
| 10/07/2004 | US20040198818 Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof |
| 10/07/2004 | US20040198817 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
| 10/07/2004 | US20040198816 Administering mixture of anesthetic and adrenergic receptor antagonist; reverse with low dosage of adrenergic receptor antagonist; used for hair grafting |
| 10/07/2004 | US20040198815 Antimicrobial and anticancer properties of methyl-beta-orcinolcarboxylate from lichen (Everniastrum cirrhatum) |
| 10/07/2004 | US20040198812 Pseudopolymorphic forms of carvedilol |
| 10/07/2004 | US20040198811 Use of enantiomeric pure escitalopram |
| 10/07/2004 | US20040198810 Use of enantiomeric pure escitalopram |
| 10/07/2004 | US20040198809 Use of enantiomeric pure escitalopram |
| 10/07/2004 | US20040198808 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 10/07/2004 | US20040198807 mixture of ferulic acid with caffeic and, or chlorogenic acid; food, beverage |
| 10/07/2004 | US20040198806 Antiproliferative agents; synergistic mixture of anticarcinogenic agents with antiemetic |
| 10/07/2004 | US20040198805 Novel crystalline form of dorzolamide hydrochloride |
| 10/07/2004 | US20040198804 i.e., 3-[3,5-dimethyl-4-[3-oxo-3-(piperazin-1-ylpropyl]-1H-pyrrol-2-ylmethylene]-1,3-dihydroindol-2-one, in which the piperazine may be 4-substituted with methyl or ethyl and salts are tyrosine kinase inhibitors used to treat various kinds of cancer |
| 10/07/2004 | US20040198803 Method for reducing intraocular pressure using indole derivatives |
| 10/07/2004 | US20040198801 Antiinflammatory agents; sepsis |
| 10/07/2004 | US20040198800 Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents |
| 10/07/2004 | US20040198799 Methods of increasing endogenous testosterone levels |
| 10/07/2004 | US20040198798 Method for inhibiting tumor angiogenesis and tumor growth |
| 10/07/2004 | US20040198796 Compounds and methods for treating urinary incontinence |
| 10/07/2004 | US20040198795 Substituted imidazoliums and methods of use therefor |
| 10/07/2004 | US20040198792 Imidazole derivatives modulating the sodium channels |
| 10/07/2004 | US20040198789 hypotensive agents; synergistic mixture containing angiotensin receptor blockers |
| 10/07/2004 | US20040198788 Synergistic mixture with acylcoenzyme: cholesterol transferase inhibitor; arteriosclerosis; antiischemic agents; cardiovascular disorders |
| 10/07/2004 | US20040198787 Efficient process for the preparation of a factor Xa inhibitor |
| 10/07/2004 | US20040198784 Antitumor agents for treating a tumor of the colon or rectum in a mammal; N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt |
| 10/07/2004 | US20040198783 Targeted bone marrow protection agents |
| 10/07/2004 | US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198776 Methods for increasing leptin levels using nicotinic acid compounds |
| 10/07/2004 | US20040198775 Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulators |
| 10/07/2004 | US20040198772 Antiarthritic agents |
| 10/07/2004 | US20040198771 medical equipment for angioplasty |
| 10/07/2004 | US20040198770 Uses for l-tetrahydropalmatine |
| 10/07/2004 | US20040198769 Composition (RUCD) for protecting and/or repairing DNA from oxidative damages and a method thereof |
| 10/07/2004 | US20040198768 Method for inhibiting 5-lipoxygenase using a benzoxazole derivative or an analogue thereof |
| 10/07/2004 | US20040198766 Chemical compounds |
| 10/07/2004 | US20040198764 Prodrugs of imidazopyridine derivatives |
| 10/07/2004 | US20040198763 Usign tacrolimus; eye drops |
| 10/07/2004 | US20040198761 reducing pain; side effect reduction; plant extracts |
| 10/07/2004 | US20040198760 Anticancer agents ; skins, prostate glands, lungs, breasts, leukemia, central nervous system, colon |
| 10/07/2004 | US20040198757 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 10/07/2004 | US20040198756 Piperidien compound; bactericide |
| 10/07/2004 | US20040198755 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials |
| 10/07/2004 | US20040198754 using theobromine; controlling weight; side effect reduction |
| 10/07/2004 | US20040198753 administering adenosine receptor antagonist ; side effect reduction; parkinson's disease |
| 10/07/2004 | US20040198752 Administering retinoids with epidermal growth factor receptor inhibitors |
| 10/07/2004 | US20040198751 Pyrazolo-pyrimidine compound; anticancer agents |
| 10/07/2004 | US20040198749 Methods of using sodium channel blockers |